News
Issued by Emerging Growth Research, not SBC Medical Group Holdings Incorporated
Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q3:25 Results
December 1, 2025 · View original source (Newsfile)
It isn’t one of SBC Medical Group Holdings Incorporated’s news releases, so 6ix doesn’t show it on SBC Medical Group Holdings Incorporated’s page or send it as an alert.